BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 19625060)

  • 1. Uropathogen interaction with the surface of urological stents using different surface properties.
    Lange D; Elwood CN; Choi K; Hendlin K; Monga M; Chew BH
    J Urol; 2009 Sep; 182(3):1194-200. PubMed ID: 19625060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of triclosan-eluting ureteral stents against common bacterial uropathogens.
    Chew BH; Cadieux PA; Reid G; Denstedt JD
    J Endourol; 2006 Nov; 20(11):949-58. PubMed ID: 17144870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diamond-like carbon coatings on ureteral stents--a new strategy for decreasing the formation of crystalline bacterial biofilms?
    Laube N; Kleinen L; Bradenahl J; Meissner A
    J Urol; 2007 May; 177(5):1923-7. PubMed ID: 17437849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ureteral stents: coil strength and durometer.
    Hendlin K; Dockendorf K; Horn C; Pshon N; Lund B; Monga M
    Urology; 2006 Jul; 68(1):42-5. PubMed ID: 16844448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of initial biofilm formation on ureteral stents using a sustained releasing varnish containing chlorhexidine: in vitro study.
    Zelichenko G; Steinberg D; Lorber G; Friedman M; Zaks B; Lavy E; Hidas G; Landau EH; Gofrit ON; Pode D; Duvdevani M
    J Endourol; 2013 Mar; 27(3):333-7. PubMed ID: 22970837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial adhesion and growth on a polymer brush-coating.
    Nejadnik MR; van der Mei HC; Norde W; Busscher HJ
    Biomaterials; 2008 Oct; 29(30):4117-21. PubMed ID: 18674814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial adherence to ofloxacin-blended polylactone-coated self-reinforced L-lactic acid polymer urological stents.
    Multanen M; Talja M; Hallanvuo S; Siitonen A; Välimaa T; Tammela TL; Seppälä J; Törmälä P
    BJU Int; 2000 Dec; 86(9):966-9. PubMed ID: 11119087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary stent clogging solved by nanotechnology? In vitro study of inorganic-organic sol-gel coatings for teflon stents.
    Seitz U; Block A; Schaefer AC; Wienhold U; Bohnacker S; Siebert K; Seewald S; Thonke F; Wulff H; De Weerth A; Soehendra N
    Gastroenterology; 2007 Jul; 133(1):65-71. PubMed ID: 17631132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination?
    Edmiston CE; Seabrook GR; Goheen MP; Krepel CJ; Johnson CP; Lewis BD; Brown KR; Towne JB
    J Am Coll Surg; 2006 Oct; 203(4):481-9. PubMed ID: 17000391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of ureteral stent compression force and its role in malignant obstruction.
    Christman MS; L'esperance JO; Choe CH; Stroup SP; Auge BK
    J Urol; 2009 Jan; 181(1):392-6. PubMed ID: 19010490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-biofilm properties of chitosan-coated surfaces.
    Carlson RP; Taffs R; Davison WM; Stewart PS
    J Biomater Sci Polym Ed; 2008; 19(8):1035-46. PubMed ID: 18644229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Novel 3,4-Dihydroxyphenylalanine-Containing Antimicrobial Polymers for the Prevention of Uropathogen Attachment to Urinary Biomaterials.
    MacPhee RA; Koepsel J; Tailly T; Vangala SK; Brennan L; Cadieux PA; Burton JP; Wattengel C; Razvi H; Dalsin J
    J Endourol; 2019 Jul; 33(7):590-597. PubMed ID: 31140304
    [No Abstract]   [Full Text] [Related]  

  • 13. In Vitro Effects of a Novel Coating Agent on Bacterial Biofilm Development on Ureteral Stents.
    Szell T; Dressler FF; Goelz H; Bluemel B; Miernik A; Brandstetter T; Scherag F; Schoeb DS
    J Endourol; 2019 Mar; 33(3):225-231. PubMed ID: 30458115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in ureteral stent design, materials and coatings.
    Chew BH; Duvdevani M; Denstedt JD
    Expert Rev Med Devices; 2006 May; 3(3):395-403. PubMed ID: 16681460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid method of impregnating endotracheal tubes and urinary catheters with gendine: a novel antiseptic agent.
    Chaiban G; Hanna H; Dvorak T; Raad I
    J Antimicrob Chemother; 2005 Jan; 55(1):51-6. PubMed ID: 15574478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental research in vitro on antibacterial property and biocompatibility of silver-containing hydroxyapatite coating].
    Ruan H; Liu J; Fan C; Zheng X; Chen Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Feb; 23(2):226-30. PubMed ID: 19275110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wire-based ureteral stents: impact on tensile strength and compression.
    Pedro RN; Hendlin K; Kriedberg C; Monga M
    Urology; 2007 Dec; 70(6):1057-9. PubMed ID: 18158013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial adherence to silver nitrate coated poly-L-lactic acid urological stents in vitro.
    Multanen M; Talja M; Hallanvuo S; Siitonen A; Välimaa T; Tammela TL; Seppälä J; Törmälä P
    Urol Res; 2000 Oct; 28(5):327-31. PubMed ID: 11127712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.
    Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2009 Oct; 73(2):199-206. PubMed ID: 19541460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic pretreatment of hydrogel ureteral stent.
    John T; Rajpurkar A; Smith G; Fairfax M; Triest J
    J Endourol; 2007 Oct; 21(10):1211-6. PubMed ID: 17949328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.